Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Filters applied: . Clear all
Page 1
Comparative analysis of systemic oncological treatments and best supportive care for advanced gastresophageal cancer: A comprehensive scoping review and evidence map.
Marilina S, Adriana M, Anna S, Roberto AD, Nicolás M, Jesús QM, Javier B, Carolina R, Josefina S, Gerardo RG, Ivan S, Gerard U, Xavier BC; Appropriateness of Systemic Oncological Treatments for Advanced Cancer (ASTAC) Research Group. Marilina S, et al. J Evid Based Med. 2023 Jun;16(2):216-236. doi: 10.1111/jebm.12539. Epub 2023 Jun 12. J Evid Based Med. 2023. PMID: 37303304 Review.
Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map.
Salazar J, Bracchiglione J, Acosta-Dighero R, Meza N, Meade AG, Quintana MJ, Requeijo C, Rodríguez-Grijalva G, Santero M, Selva A, Solà I, Bonfill X; Appropriateness of Systemic Oncological Treatments for Advanced Cancer (ASTAC) Research Group. Salazar J, et al. Support Care Cancer. 2023 Jan 9;31(2):100. doi: 10.1007/s00520-022-07564-8. Support Care Cancer. 2023. PMID: 36622453 Free PMC article. Review.
Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review.
Salazar J, Bracchiglione J, Savall-Esteve O, Antequera A, Bottaro-Parra D, Gutiérrez-Valencia M, Martínez-Peralta S, Pericay C, Tibau A, Bonfill X; Appropriateness of Systemic Oncological Treatments for Advanced Cancer (ASTAC) Research Group. Salazar J, et al. BMC Cancer. 2023 Aug 12;23(1):748. doi: 10.1186/s12885-023-11207-4. BMC Cancer. 2023. PMID: 37573294 Free PMC article.
This uncertainty is further highlighted when considering immunotherapy or a second line of chemotherapy and thus, best supportive care would be an appropriate alternative. Future studies should assess their impact on all patient-important outcomes to inform patients in set …
This uncertainty is further highlighted when considering immunotherapy or a second line of chemotherapy and thus, best supportive care would …
Anticancer Drugs Compared to No Anticancer Drugs in Patients with Advanced Hepatobiliary Cancer: A Mapping Review and Evidence Gap Map.
Requeijo C, Bracchiglione J, Meza N, Acosta-Dighero R, Salazar J, Santero M, Meade AG, Quintana MJ, Rodríguez-Grijalva G, Selva A, Solà I, Urrútia G, Bonfill Cosp X; Appropriateness of Systemic Oncological Treatments for Advanced Cancer (ASTAC) Research Group. Requeijo C, et al. Clin Epidemiol. 2023 Nov 10;15:1069-1085. doi: 10.2147/CLEP.S431498. eCollection 2023. Clin Epidemiol. 2023. PMID: 38025841 Free PMC article. Review.